OMC
ORIC icon

Oasis Management Company’s Oric Pharmaceuticals ORIC Stock Holding History

Oasis Management Company’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-272,480
Closed -$1.6M – 100
2022
Q4 		$1.6M Hold
272,480
– – 0.32% 41
2022
Q3 		$872K Hold
272,480
– – 0.15% 62
2022
Q2 		$1.22M Buy
+272,480
New +$1.09M 0.21% 43

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Oasis Management Company's ORIC Position: Q1 2023 in Review

Oasis Management Company sold out of Oric Pharmaceuticals (ORIC) in Q1 2023, closing a stake of 272,480 shares — an estimated $1.6M sold.

Oasis Management Company first reported a position in ORIC in Q2 2022 and held it in 3 quarters. The position peaked at $1.6M in Q4 2022. 70 funds tracked by Wall St. Rank hold ORIC as of Q1 2023.

  • Oasis Management Company reported no remaining Oric Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 272,480 Oric Pharmaceuticals shares in Q1 2023, an estimated $1.6M.
  • Oasis Management Company first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Oric Pharmaceuticals position peaked at $1.6M in Q4 2022.
  • 70 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.